INOVIO PHARMACEUTICALS, INC. Other Non-Current Liabilities
INOVIO PHARMACEUTICALS, INC. (INO) had Other Non-Current Liabilities of $0 as of 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-03-01
- 2022-12-31: Other Liabilities, Noncurrent $0.00.
- 2022-09-30: Other Liabilities, Noncurrent $710.35K.
- 2022-06-30: Other Liabilities, Noncurrent $0.00.
- 2022-03-31: Other Liabilities, Noncurrent $0.00.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-01 |
| 2022-09-30 | $710.35K 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-09 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 |
| 2021-12-31 | $14.83K 10-K · filed 2023-03-01 |
| 2021-09-30 | $64.14K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $64.14K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $64.14K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $57.66K 10-K · filed 2022-03-01 |
| 2020-09-30 | $39.78K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $66.63K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $73.44K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $36.94K 10-K · filed 2021-03-01 |
| 2019-09-30 | $50.34K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $50.76K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $64.26K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $87.33K 10-K · filed 2020-03-12 |
| 2018-09-30 | $99.67K 10-Q · filed 2018-11-08 |
| 2017-12-31 | $0.00 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |